US FDA reveals plans for single cancer drug regulation centre Scheme is part of US government Cancer Moonshot initiative
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News EU regulator wants more advanced therapies Only a handful of products have reached the market in eight years.
News FDA asks for more data on Sarepta's muscular dystrophy drug Regulator asks for more data from ongoing trial.
Cancer Novartis' Afinitor gets new EU cancer use Novartis’ Afinitor has been approved in a new cancer indication in Europe – but faces potential competition from newer drugs.
News Sanofi gives up on amlitelimab in atopic dermatitis Sanofi has stopped development of anti-OX40L drug amlitelimab in atopic dermatitis, a major blow to what was once viewed as a 'pipeline-in-a-product'.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
